Investing
Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)
Published:
Last Updated:
These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls:
Abbott Laboratories (NYSE: ABT) Cut to Sell at Citigroup.
Aeropostale (NYSE: ARO) Raised to Neutral at Piper Jaffray.
Biogen Idec (NASDAQ: BIIB) Started as Neutral at Piper Jaffray.
Celgene (NASDAQ: CELG) Started as Overweight at Piper Jaffray.
China Advanced Construction Materials (NASDAQ: CADC) Started as Buy at Roth Capital.
Facet Biotech (NASDAQ: FACT) Cut to Market Perform at BMO Capital.
HSBC (NYSE: HBC) Cut to Neutral at Goldman Sachs.
Luminex (NASDAQ: LMNX) Started as Buy at Jefferies.
New Oriental Education (NYSE: EDU) Started as Buy at Deutsche Bank.
Pacific Sunwear of California (NASDAQ: PSUN) Cut to Market Perform at FBR.
Silicon Graphics International (NYSE: SGI) Started as Market Perform at Morgan Keegan.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.